Der Alpaca-Monoklonal Anti-SARS-CoV-2 Nucleocapsid-Antikörper wurde für IF und ICC validiert. Er ist geeignet zum Nachweis von SARS-CoV-2 Nucleocapsid in Proben aus SARS Coronavirus-2 (SARS-CoV-2).
}
SARS-CoV-2 N
Reaktivität: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
ELISA, IF, Neut
Wirt: Human
Monoclonal
CR3018 (03-018)
unconjugated
Recombinant Antibody
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconsitute with 250 µL 50% glycerol for storage at -80 °C
Buffer
sdAbs are lyophilized from PBS pH 7.4.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Vials containing lyophilized protein can be stored at 4°C for up to 6 months. Vials containing reconstituted protein should be stored at -20°C or below.
Target
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
Andere Bezeichnung
Nucleocapsid from SARS-CoV-2
Hintergrund
The nucleocapsid (N) protein of SARS-CoV-2 is an abundant RNA-binding protein critical for the packaging of the single-stranded RNA viral genome. Due to its abundance, it is an interesting target for antibody detection in biopsies and tissue. The protein N is also present inside virion particles bound to single-stranded RNA.